RBC Capital Downgrades Celgene (CELG) to Sector Perform Following Acquisition
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams downgraded Celgene (NASDAQ: CELG) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
